Artiva Biotherapeutics Target Price

See Artiva Biotherapeutics's analyst price targets ($38) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$11.77

Average Target Price

$37.50

218.6% upside

2 analysts in the last 4 months

High: $40 | Low: $35

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-05-11	WedbushDavid Nierengarten	$40	239.8% upside
2026-05-08	H.C. Wainwright	$35	197.4% upside
2024-08-13	WedbushDavid Nierengarten	$18	52.9% upside
2024-08-13	NeedhamGil Blum	$23	95.4% upside

Artiva Biotherapeutics (ARTV) FAQ

The latest target price for ARTV is $38. Investors often review this figure alongside Artiva Biotherapeutics's historical trend and sector peers before judging valuation or financial health.

Artiva Biotherapeutics trades near $11.77 while the consensus target sits at $38 (218.6% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting ARTV's target price ($38), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.